Skip to content

Clinical trials

Phase 1/2 Small Cell Lung Carcinoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1/2 Country / region: Spain Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20141
20151
20161
20173
20191
20203
20212
20221
20231
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed7
Terminated3
Active, not recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
BioNTech SE2
Boehringer Ingelheim2
Merck Sharp & Dohme LLC2
Antonio Calles Blanco1
Bristol-Myers Squibb1
Fundacion Oncosur1
G1 Therapeutics, Inc.1
IDP Discovery Pharma S.L.1
ImmunoGen, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma23
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms4
Endometrial Neoplasms4
Neoplasm Metastasis4
Triple Negative Breast Neoplasms4
Breast Neoplasms3
Melanoma3
Neoplasms3
Ovarian Neoplasms3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.